These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 25363759)
1. An analysis approach to identify specific functional sites in orthologous proteins using sequence and structural information: application to neuroserpin reveals regions that differentially regulate inhibitory activity. Lee TW; Yang AS; Brittain T; Birch NP Proteins; 2015 Jan; 83(1):135-52. PubMed ID: 25363759 [TBL] [Abstract][Full Text] [Related]
2. Human neuroserpin: structure and time-dependent inhibition. Ricagno S; Caccia S; Sorrentino G; Antonini G; Bolognesi M J Mol Biol; 2009 Apr; 388(1):109-21. PubMed ID: 19265707 [TBL] [Abstract][Full Text] [Related]
3. Understanding the specificity of serpin-protease complexes through interface analysis. Rashid Q; Kapil C; Singh P; Kumari V; Jairajpuri MA J Biomol Struct Dyn; 2015; 33(6):1352-62. PubMed ID: 25052369 [TBL] [Abstract][Full Text] [Related]
4. The 2.1-A crystal structure of native neuroserpin reveals unique structural elements that contribute to conformational instability. Takehara S; Onda M; Zhang J; Nishiyama M; Yang X; Mikami B; Lomas DA J Mol Biol; 2009 Apr; 388(1):11-20. PubMed ID: 19285087 [TBL] [Abstract][Full Text] [Related]
5. Physiological and pathological functions of neuroserpin: Regulation of cellular responses through multiple mechanisms. Lee TW; Tsang VW; Loef EJ; Birch NP Semin Cell Dev Biol; 2017 Feb; 62():152-159. PubMed ID: 27639894 [TBL] [Abstract][Full Text] [Related]
6. Neuroserpin is expressed in the pituitary and adrenal glands and induces the extension of neurite-like processes in AtT-20 cells. Hill RM; Parmar PK; Coates LC; Mezey E; Pearson JF; Birch NP Biochem J; 2000 Feb; 345 Pt 3(Pt 3):595-601. PubMed ID: 10642518 [TBL] [Abstract][Full Text] [Related]
7. Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1. Wardell MR; Chang WS; Bruce D; Skinner R; Lesk AM; Carrell RW Biochemistry; 1997 Oct; 36(42):13133-42. PubMed ID: 9335576 [TBL] [Abstract][Full Text] [Related]
8. High-density mutagenesis by combined DNA shuffling and phage display to assign essential amino acid residues in protein-protein interactions: application to study structure-function of plasminogen activation inhibitor 1 (PAI-I). Stoop AA; Jespers L; Lasters I; Eldering E; Pannekoek H J Mol Biol; 2000 Sep; 301(5):1135-47. PubMed ID: 10966811 [TBL] [Abstract][Full Text] [Related]
9. PEDF and the serpins: phylogeny, sequence conservation, and functional domains. Tombran-Tink J; Aparicio S; Xu X; Tink AR; Lara N; Sawant S; Barnstable CJ; Zhang SS J Struct Biol; 2005 Aug; 151(2):130-50. PubMed ID: 16040252 [TBL] [Abstract][Full Text] [Related]
10. Identification of a novel targeting sequence for regulated secretion in the serine protease inhibitor neuroserpin. Ishigami S; Sandkvist M; Tsui F; Moore E; Coleman TA; Lawrence DA Biochem J; 2007 Feb; 402(1):25-34. PubMed ID: 17040209 [TBL] [Abstract][Full Text] [Related]
11. Tissue-type plasminogen activator and neuroserpin: a well-balanced act in the nervous system? Yepes M; Lawrence DA Trends Cardiovasc Med; 2004 Jul; 14(5):173-80. PubMed ID: 15261888 [TBL] [Abstract][Full Text] [Related]
12. The stability and activity of human neuroserpin are modulated by a salt bridge that stabilises the reactive centre loop. Noto R; Randazzo L; Raccosta S; Caccia S; Moriconi C; Miranda E; Martorana V; Manno M Sci Rep; 2015 Sep; 5():13666. PubMed ID: 26329378 [TBL] [Abstract][Full Text] [Related]
13. Mutant Neuroserpin (S49P) that causes familial encephalopathy with neuroserpin inclusion bodies is a poor proteinase inhibitor and readily forms polymers in vitro. Belorgey D; Crowther DC; Mahadeva R; Lomas DA J Biol Chem; 2002 May; 277(19):17367-73. PubMed ID: 11880376 [TBL] [Abstract][Full Text] [Related]
14. The cowpox virus serpin SPI-3 complexes with and inhibits urokinase-type and tissue-type plasminogen activators and plasmin. Turner PC; Baquero MT; Yuan S; Thoennes SR; Moyer RW Virology; 2000 Jul; 272(2):267-80. PubMed ID: 10873770 [TBL] [Abstract][Full Text] [Related]
15. Neuroserpin: a selective inhibitor of tissue-type plasminogen activator in the central nervous system. Yepes M; Lawrence DA Thromb Haemost; 2004 Mar; 91(3):457-64. PubMed ID: 14983220 [TBL] [Abstract][Full Text] [Related]
16. The structure of a Michaelis serpin-protease complex. Ye S; Cech AL; Belmares R; Bergstrom RC; Tong Y; Corey DR; Kanost MR; Goldsmith EJ Nat Struct Biol; 2001 Nov; 8(11):979-83. PubMed ID: 11685246 [TBL] [Abstract][Full Text] [Related]
17. Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent. Yepes M; Sandkvist M; Coleman TA; Moore E; Wu JY; Mitola D; Bugge TH; Lawrence DA J Clin Invest; 2002 Jun; 109(12):1571-8. PubMed ID: 12070304 [TBL] [Abstract][Full Text] [Related]
18. Refolding and polymerization pathways of neuroserpin. Takehara S; Zhang J; Yang X; Takahashi N; Mikami B; Onda M J Mol Biol; 2010 Nov; 403(5):751-62. PubMed ID: 20691191 [TBL] [Abstract][Full Text] [Related]
19. Comparative analysis and expression of neuroserpin in Xenopus laevis. de Groot DM; Pol C; Martens GJ Neuroendocrinology; 2005; 82(1):11-20. PubMed ID: 16319501 [TBL] [Abstract][Full Text] [Related]
20. The low density lipoprotein receptor-related protein modulates protease activity in the brain by mediating the cellular internalization of both neuroserpin and neuroserpin-tissue-type plasminogen activator complexes. Makarova A; Mikhailenko I; Bugge TH; List K; Lawrence DA; Strickland DK J Biol Chem; 2003 Dec; 278(50):50250-8. PubMed ID: 14522960 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]